American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1965)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (5)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1362)

Results (4047)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A single-arm phase 2 trial of trametinib in patients with locally advanced or metastatic epithelioid hemangioendothelioma
    Journal Article

    Schuetze, S. M.; Ballman, K. V.; Heise, R.; Ganjoo, K. N.; Davis, E. J.; George, S.; Burgess, M. A.; Choy, E.; Shepard, D. R.; Tinoco, G.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Androgen deprivation therapy drives a distinct immune phenotype in localized prostate cancer
    Journal Article

    Dallos, M. C.; Obradovic, A. Z.; McCann, P.; Chowdhury, N.; Pratapa, A.; Aggen, D. H.; Gaffney, C.; Autio, K. A.; Virk, R. K.; De Marzo, A. M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • GDF-15 predicts epithelioid hemangioendothelioma aggressiveness and is downregulated by sirolimus through ATF4/ATF5 suppression
    Journal Article

    Stacchiotti, S.; Martini, S.; Pasquali, S.; Frezza, A. M.; Beretta, A.; Percio, S.; Lecchi, M.; Tortoreto, M.; Barisella, M.; Collini, P.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The intrauterine device: How to deploy this strategy in the molecular world?
    Review

    Johannet, P.; Friedman, C. F.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase I first-in-human study of ABBV-011, a seizure-related homolog protein 6-targeting antibody-drug conjugate, in patients with small cell lung cancer
    Journal Article

    Morgensztern, D.; Ready, N.; Johnson, M. L.; Dowlati, A.; Choudhury, N.; Carbone, D. P.; Schaefer, E.; Arnold, S. M.; Puri, S.; Piotrowska, Z.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The impact of Li-Fraumeni and germline retinoblastoma mutations on leiomyosarcoma initiation, outcomes, and genetic testing recommendations
    Journal Article

    Dermawan, J. K.; Abramson, D. H.; Chiang, S.; Hensley, M. L.; Tap, W. D.; Movva, S.; Maki, R. G.; Mandelker, D.; Antonescu, C. R.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Proportional hazards violations in phase III cancer clinical trials: A potential source of trial misinterpretation
    Journal Article

    Lin, T. A.; McCaw, Z. R.; Koong, A.; Lin, C.; Abi Jaoude, J.; Patel, R.; Kouzy, R.; El Alam, M. B.; Sherry, A. D.; Noticewala, S. S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • HER2 antibody-drug conjugates are active against desmoplastic small round cell tumor
    Journal Article

    Zhang, T.; Febres-Aldana, C. A.; Liu, Z.; Dix, J. M.; Cheng, R.; Dematteo, R. G.; Lui, A. J. W.; Khodos, I.; Gili, L.; Mattar, M. S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Update on Recommendations for surveillance for children with predisposition to hematopoietic malignancy
    Review

    Maese, L. D.; Wlodarski, M. W.; Kim, S. Y.; Bertuch, A. A.; Bougeard, G.; Chang, V. Y.; Godley, L. A.; Khincha, P. P.; Kuiper, R. P.; Lesmana, H.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: